Home
Conditions
Urologic Neoplasms

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,952 public trials 630 recruiting studies

Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Completed

First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy

NCT00389155

Conditions: Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +19 more
Locations: University Of Alabama At Birmingham Birmingham, Alabama, United States

Acrc/Arizona Clinical Research Center, Inc. Tucson, Arizona, United States

Tower Hematology Oncology Medical Group Beverly Hills, California, United States

Local Institution Concord, California, United States

View all 112 locations

View Trial Details

Completed

Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors

NCT00625456

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +38 more
Locations: Billings Clinic Billings, Montana, United States

University of Pennsylvania Philadelphia, Pennsylvania, United States

Cancer Centers of the Carolinas Greenville, South Carolina, United States

Ottawa Health Research Institute Ottawa, Ontario, Canada

View Trial Details

Completed

Phase I Mitomycin Combined With Bacillus Calmette-Guérin (BCG) for Bladder Cancer

NCT02311101

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +9 more
Locations: The University of Texas Health Science Center San Antonio, Texas, United States

View Trial Details

Completed

Sunitinib for Metastatic Renal Cell Cancer With Imaging Biomarker Assessments for the Early Prediction of Tumor Response

NCT00694096

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Huntsman Cancer Institute Salt Lake City, Utah, United States

View Trial Details

Completed

Neoadjuvant ABI-007, Carboplatin and Gemcitabine in Locally Advanced Bladder Cancer

NCT00585689

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: University of Michigan Ann Arbor, Michigan, United States

View Trial Details

Completed

Sunitinib in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer

NCT00459875

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors

NCT00024258

Conditions: Adnexal Diseases, Brain and Central Nervous System Tumors, Central Nervous System Neoplasms, +65 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Sunitinib Plus Temsirolimus in Patients With Renal Cell Cancer (RCC)

NCT01122615

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

B-Receptor Signaling in Cardiomyopathy

NCT01135849

Conditions: Adenocarcinoma, Adenoma, Amyloidosis, +140 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details

Completed

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

NCT00161187

Conditions: Adenocarcinoma, Adnexal Diseases, Blast Crisis, +151 more
Locations: Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School New Brunswick, New Jersey, United States

View Trial Details

Urologic Neoplasms

Urologic Neoplasms trial results

Related conditions